Par Nijhawan
Overview
Par Nijhawan is a Canadian entrepreneur and investor specializing in the biotechnology sector. He is the Chief Executive Officer and Founder of Edesa Biotech, a clinical-stage biopharmaceutical company focused on developing treatments for immuno-inflammatory diseases. Under his leadership, Edesa Biotech has advanced a pipeline of therapies targeting conditions such as vitiligo, allergic contact dermatitis, and acute respiratory distress syndrome. In addition to his role at Edesa Biotech, Dr. Nijhawan has been involved in various entrepreneurial ventures. He founded Medical Futures Inc., a specialty pharmaceutical company that was successfully sold to Tribute Pharmaceuticals in 2015. He also established Exzell Pharma, a Canadian-based pharmaceutical organization, and led Digestive Health Clinic, which became one of Canada's largest providers of private endoscopy services. His strategic investments and leadership have significantly contributed to the growth and success of these companies. Dr. Nijhawan's commitment to the biotechnology industry is further demonstrated by his strategic investment in Edesa Biotech. In October 2024, an entity affiliated with him invested up to $5 million in the company, including an immediate investment of approximately $1.5 million. This investment underscores his confidence in Edesa's development pipeline and strategic initiatives. His extensive experience in finance, marketing, and business development continues to drive innovation and growth within the biotechnology sector.
Investment Focus
- Innovative biotechnology companies with a strong development pipeline
- Management teams with a proven track record
- Opportunities in immuno-inflammatory disease treatments
Portfolio Companies
Reach Par Nijhawan directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Par Nijhawan
What sectors does Par Nijhawan invest in?
Par Nijhawan invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in Ontario, Canada. Par Nijhawan is listed as a angel investor in the ConnectSafely investor database.
What stage does Par Nijhawan invest at?
Par Nijhawan backs companies at Seed, Early Stage and Growth, writing cheques of 1M - 5M.
Which regions does Par Nijhawan invest in?
Par Nijhawan invests across United States and Canada.
What companies has Par Nijhawan invested in?
Par Nijhawan's portfolio includes Edesa Biotech, Medical Futures Inc., Exzell Pharma and Digestive Health Clinic.
Last updated · Source: ConnectSafely investor database
